Cargando…
Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies
Recently, a number of observational studies have suggested that use of statins reduces mortality in patients suffering from chronic obstructive pulmonary disease (COPD). To obtain a more valid assessment, we update the meta-analysis of the effect of statins on COPD exacerbation and mortality. We sea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641186/ https://www.ncbi.nlm.nih.gov/pubmed/29069843 http://dx.doi.org/10.18632/oncotarget.20304 |
_version_ | 1783271179799232512 |
---|---|
author | Li, Wen-Feng Huang, Yu-Qing Huang, Cheng Feng, Ying-Qing |
author_facet | Li, Wen-Feng Huang, Yu-Qing Huang, Cheng Feng, Ying-Qing |
author_sort | Li, Wen-Feng |
collection | PubMed |
description | Recently, a number of observational studies have suggested that use of statins reduces mortality in patients suffering from chronic obstructive pulmonary disease (COPD). To obtain a more valid assessment, we update the meta-analysis of the effect of statins on COPD exacerbation and mortality. We searched for eligible articles using PubMed, Medline, Embase, the Cochrane Central Register of Controlled Trials, Cochrane Databases and Web of Science between January 2006 and February 2017, with no restrictions. The hazard ratio (HR) with 95% confidence interval (CI) was estimated. Publication bias was evaluated by funnel plot and Begg's test. Sensitivity analyses were also conducted. Twenty studies with a total of 303,981 patients were included. Thirteen articles provided data on all-cause mortality (165,221 participants), and the pooled hazard ratio of 0.65 (95% CI: 0.57–0.74, P < 0.001). Nine cohorts involving 155,435 patients reported data for COPD exacerbation with or without hospitalization, and they gave a HR of 0.58(95%CI: 0.48–0.72, P < 0.001). Our systematic review of exclusively observational studies showed a clear benefit of statins for patients suffering from COPD. |
format | Online Article Text |
id | pubmed-5641186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56411862017-10-24 Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies Li, Wen-Feng Huang, Yu-Qing Huang, Cheng Feng, Ying-Qing Oncotarget Meta-Analysis Recently, a number of observational studies have suggested that use of statins reduces mortality in patients suffering from chronic obstructive pulmonary disease (COPD). To obtain a more valid assessment, we update the meta-analysis of the effect of statins on COPD exacerbation and mortality. We searched for eligible articles using PubMed, Medline, Embase, the Cochrane Central Register of Controlled Trials, Cochrane Databases and Web of Science between January 2006 and February 2017, with no restrictions. The hazard ratio (HR) with 95% confidence interval (CI) was estimated. Publication bias was evaluated by funnel plot and Begg's test. Sensitivity analyses were also conducted. Twenty studies with a total of 303,981 patients were included. Thirteen articles provided data on all-cause mortality (165,221 participants), and the pooled hazard ratio of 0.65 (95% CI: 0.57–0.74, P < 0.001). Nine cohorts involving 155,435 patients reported data for COPD exacerbation with or without hospitalization, and they gave a HR of 0.58(95%CI: 0.48–0.72, P < 0.001). Our systematic review of exclusively observational studies showed a clear benefit of statins for patients suffering from COPD. Impact Journals LLC 2017-08-17 /pmc/articles/PMC5641186/ /pubmed/29069843 http://dx.doi.org/10.18632/oncotarget.20304 Text en Copyright: © 2017 Li et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Meta-Analysis Li, Wen-Feng Huang, Yu-Qing Huang, Cheng Feng, Ying-Qing Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
title | Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
title_full | Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
title_fullStr | Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
title_full_unstemmed | Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
title_short | Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
title_sort | statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies |
topic | Meta-Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641186/ https://www.ncbi.nlm.nih.gov/pubmed/29069843 http://dx.doi.org/10.18632/oncotarget.20304 |
work_keys_str_mv | AT liwenfeng statinsreduceallcausemortalityinchronicobstructivepulmonarydiseaseanupdatedsystematicreviewandmetaanalysisofobservationalstudies AT huangyuqing statinsreduceallcausemortalityinchronicobstructivepulmonarydiseaseanupdatedsystematicreviewandmetaanalysisofobservationalstudies AT huangcheng statinsreduceallcausemortalityinchronicobstructivepulmonarydiseaseanupdatedsystematicreviewandmetaanalysisofobservationalstudies AT fengyingqing statinsreduceallcausemortalityinchronicobstructivepulmonarydiseaseanupdatedsystematicreviewandmetaanalysisofobservationalstudies |